Monoclonal Antibodies for the Treatment of Hematologic Malignancies: Schedule and Maintenance Therapy
To access this article, please choose from the options below
PII: S0037-1963(08)00007-3
doi:10.1053/j.seminhematol.2008.02.006
© 2008 Elsevier Inc. All rights reserved.
